Former President of the School of Naturopathic Physicians of British Columbia Joins StillCanna’s Group
Vancouver, British Columbia – (PR Newswire) – Thursday, Might 16, 2019 – StillCanna Inc. (CSE: STIL) (“STIL” or the “Firm”) is happy to announce that Dr. Brian Martin, ND has joined the StillCanna Group. Dr. Martin brings a wealth of information and expertise, together with however not restricted to:
- 25 years practising Naturopathic Drugs;
- the formulation of modern pure well being merchandise;
- former President of the School of Naturopathic Physicians of British Columbia; and
- Professional in Optimum Growing old from the American Academy of Anti-Growing old Drugs.
Dr. Martin will lead the Firm’s client and Nutraceutical and Cosmeceutical product formulations with the objective of enhancing the pure capabilities of CBD and different therapeutic cannabinoids, together with terpenes and different natural compounds. He would be the Firm’s medical consultant for business analysis, talking engagements and product formulations. Dr. Martin will consider the present Olimax product line and expects to formulate new CBD associated merchandise with a particular deal with the increasing dietary (meals and drinks) and wellness marketplaces. Explicit consideration can be directed in the direction of the feminine market, together with issues associated to the development of high quality of life, together with merchandise aiming to boost power, temper, reminiscence, libido and athletic efficiency.
“Dr. Martin has devoted his life to the proactive empowerment of the fashionable client, and has developed substantial sensible expertise and information of the present well being wants of each women and men” exclaimed Jason Dussault Chief Government Officer of StillCanna. “We anticipate that his sensible information and capabilities will make StillCanna’s CBD merchandise more and more efficient and metabolically pleasant in comparison with different merchandise at the moment out there out there. Dr. Martin will work with the Firm half time for the following 2 quarters with a watch in the direction of full time employment as we develop our product imaginative and prescient.”
“I’ve been very impressed with among the proprietary methods and applied sciences StillCanna has regarding the manufacturing and formulation of varied CBD merchandise,” acknowledged Dr. Martin. “StillCanna’s imaginative and prescient of CBD within the wellness and the worldwide Nutraceutical market is in keeping with the forms of CBD merchandise I envision. StillCanna’s CEO has robust branding and advertising abilities which, coupled with my formulation abilities, paints a really thrilling image.”
As partial compensation for the engagement of Dr. Martin, the Firm will grant 200,000 incentive inventory choices to Dr. Martin with an train worth equal to a 5% premium to the closing worth of the Firm’s widespread shares on the date of grant.
Additional to its press launch dated Might 7, 2019, the Firm has additionally issued 850,000 widespread shares to sure finders in reference to the acquisition of Olimax. In consequence, an combination of 1,300,000 widespread shares have been issued to finders in reference to the acquisition of Olimax.
About StillCanna Inc.
StillCanna Inc. (CSE: STIL) www.StillCanna.com is a Canadian early-stage life sciences firm centered on giant scale CBD extraction in Europe. The Firm feels its proprietary mental property permits it to extract CBD at a decrease value. The Firm has signed an preliminary extraction contract in Europe to be the unique extractor for Dragonfly BioSciences LLC, a United Kingdom-based provider of CBD. The Firm additionally just lately accomplished the acquisition of Olimax NT SP. Z .O.O, which is anticipated to extend the Firm’s market share within the European CBD business.
On Behalf of the Board,
Chief Government Officer and Director
E-mail: [email protected]
Cautionary Notice Relating to Ahead Trying Statements: This launch contains sure statements and data that represent forward-looking info inside the that means of relevant Canadian securities legal guidelines, together with statements concerning the enhancement of the pure capabilities of CBD and different therapeutic cannabinoids, the formulation of recent CBD associated merchandise, together with merchandise to boost power, temper, reminiscence, libido and athletic efficiency, the elevated effectiveness and metabolic friendliness of the Firm’s merchandise and the hiring of Dr. Martin as a full time worker of the Firm. Typically, forward-looking statements and data will be recognized by means of forward-looking terminology reminiscent of “intends” or “anticipates”, or variations of such phrases and phrases or statements that sure actions, occasions or outcomes “might”, “might”, “ought to” or “would” happen. Ahead-looking statements are primarily based on sure materials assumptions and evaluation made by the Firm and the opinions and estimates of administration as of the date of this press launch, together with that the Firm will have the ability to improve the pure capabilities of CBD and different therapeutic cannabinoids, that the Firm will have the ability to formulate new CBD associated merchandise, together with merchandise to boost power, temper, reminiscence, libido and athletic efficiency, that the Firm will have the ability to improve the effectiveness and metabolic friendliness of the its merchandise and that the Firm will have the ability to rent Dr. Martin as a full time worker of the Firm. Though the Firm considers these assumptions to be affordable primarily based on info at the moment out there to it, they might show to be incorrect, and the forward-looking statements on this launch are topic to quite a few dangers, uncertainties and different components that will trigger future outcomes to vary materially from these expressed or implied in such forward-looking statements. Such danger components might embody, amongst others, that the Firm will be unable to boost the pure capabilities of CBD and different therapeutic cannabinoids, that the Firm will be unable to formulate new CBD associated merchandise, together with merchandise to boost power, temper, reminiscence, libido and athletic efficiency, that the Firm will be unable to extend the effectiveness and metabolic friendliness of the its merchandise and that the Firm will be unable to rent Dr. Martin as a full time worker of the Firm. Readers are cautioned to not place undue reliance on forward-looking statements. Though administration of the Firm has tried to determine necessary components that might trigger precise outcomes to vary materially from these contained in forward-looking statements or forward-looking info, there could also be different components that trigger outcomes to not be as anticipated, estimated or meant. There will be no assurance that such statements will show to be correct, as precise outcomes and future occasions might differ materially from these anticipated in such statements. Accordingly, readers mustn’t place undue reliance on forward-looking statements and forward-looking info. Readers are cautioned that reliance on such info will not be applicable for different functions. The Firm doesn’t intend, and expressly disclaims any intention or obligation to, replace or revise any forward-looking statements whether or not on account of new info, future occasions or in any other case, besides as required by legislation.